TriNetX-enabled research drives learning at ASH 2022
In December, a contingent of our real-world data experts attended the 2022 Annual Meeting of the American Society of Hematology. Led by Chief Scientific Officer Jeffrey Brown and Senior Vice President, TriNetX Oncology GmbH Lenka Kellerman, our team spent their time...EMR or Claims? Here’s why you need both.
Meet Mateo. Mateo is a 59-year-old travel photographer who moved from Philadelphia, Pennsylvania to Phoenix, Arizona in October of 2019. Mateo sees his primary care physician (PCP) at a nearby medical center, who’s helping him manage his high blood pressure with...
Unlocking the Value of Genotypic and Phenotypic Data for Translational Research
The advent of precision medicine is revolutionizing diagnostics and treatment across a broad range of illnesses. Genetic biomarkers are increasingly using DNA, RNA and protein sequencing results, and are an integral part of the precision medicine revolution and...
Why Using Real-World Data Internally During Clinical Trial Design is a Must for Every Sponsor
A family member of mine had exhausted all his available options in his battle with cancer. There was one experimental drug that we believed would help him one last time, but his lab values were not high (sick) enough to meet the eligibility criteria for the trial. So,...